Inflammation and immune mechanisms are crucially involved in the pathophysiology of the
development, acute damage cascades, and chronic course after ischemic stroke …

Background: Stroke has become a major problem around the world, which is one of the
main causes of long-term disability. Therefore, it is important to seek a biomarker to predict …

Objective To measure the global impact of COVID-19 pandemic on volumes of IV
thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of …

Background COVID-19 infection has been known to predispose patients to both arterial and
venous thromboembolic events such as deep venous thrombosis, pulmonary embolism …

Responding to the coronavirus disease 2019 (COVID-19) pandemic has been an
unexpected and unprecedented global challenge for humanity in this century. During this …

Clonal hematopoiesis (CH) is common among older people and is associated with an
increased risk of atherosclerosis, inflammation, and shorter overall survival. Age and …

Prior to COVID-19, only two human-tropic coronaviruses resulted in epidemics and
cerebrovascular disease was rarely reported. Evidence now suggests that 1–6% of …

Neuroinflammation, for which microglia are the predominant contributors, is a significant risk
factor for cognitive dysfunction. Riboflavin (also known as vitamin B2) ameliorates cognitive …

AIM: The “2024 Guideline for the Primary Prevention of Stroke” replaces the 2014
“Guidelines for the Primary Prevention of Stroke.” This updated guideline is intended to be a …

Background and Objectives Declines in stroke admission, IV thrombolysis (IVT), and
mechanical thrombectomy volumes were reported during the first wave of the COVID-19 …